10,277 Shares in CEVA, Inc. (NASDAQ:CEVA) Bought by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC bought a new position in CEVA, Inc. (NASDAQ:CEVA) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,277 shares of the semiconductor company’s stock, valued at approximately $324,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Jane Street Group LLC boosted its stake in shares of CEVA by 206.2% during the 3rd quarter. Jane Street Group LLC now owns 137,061 shares of the semiconductor company’s stock worth $3,310,000 after buying an additional 92,295 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of CEVA by 55.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 115,979 shares of the semiconductor company’s stock worth $2,801,000 after buying an additional 41,573 shares during the last quarter. Barclays PLC boosted its stake in shares of CEVA by 389.8% during the 3rd quarter. Barclays PLC now owns 41,900 shares of the semiconductor company’s stock worth $1,011,000 after buying an additional 33,346 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of CEVA by 8.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 222,962 shares of the semiconductor company’s stock worth $5,385,000 after buying an additional 16,463 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of CEVA by 97.3% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 211,771 shares of the semiconductor company’s stock worth $5,114,000 after buying an additional 104,453 shares during the last quarter. 85.37% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on CEVA. Barclays increased their price objective on shares of CEVA from $34.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Rosenblatt Securities restated a “buy” rating and set a $35.00 price objective on shares of CEVA in a research note on Tuesday, February 11th. Finally, Northland Securities upped their target price on shares of CEVA from $31.00 to $35.00 and gave the company an “outperform” rating in a report on Monday, December 23rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $36.60.

CEVA Stock Performance

Shares of CEVA stock opened at $30.65 on Tuesday. The firm’s 50-day moving average is $33.03 and its 200-day moving average is $29.17. The stock has a market cap of $729.68 million, a price-to-earnings ratio of -82.84 and a beta of 1.32. CEVA, Inc. has a 52-week low of $16.02 and a 52-week high of $38.94.

CEVA (NASDAQ:CEVA) last released its quarterly earnings results on Thursday, February 13th. The semiconductor company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.16). CEVA had a negative net margin of 8.22% and a negative return on equity of 2.48%. Sell-side analysts predict that CEVA, Inc. will post -0.12 EPS for the current fiscal year.

CEVA Profile

CEVA, Inc provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 – 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices.